Aim/hypothesis. Although derangements of calcium and phosphate control have been emphasized as important risk factors for vascular calcification in nondiabetic haemodialysis patients, similar risk factors for diabetic haemodialysis patients are not known. We compared factors affecting peripheral vascular calcification between haemodialysis patients with and without diabetes. Methods. We examined 421 patients on maintenance haemodialysis. There were 89 patients with Type II (non-insulin-dependent) diabetes mellitus (53 men and 36 women, 62±10 years old) and 332 patients without diabetes (192 men and 140 women, 59±13 years old). Hand roentgenography was carried out, and visible vascular calcification of the hand arteries was evaluated.
The population of diabetic patients has increased dramatically, and the leading cause of end-stage renal disease is diabetic nephropathy, in Japan, the United States, and Europe. Vascular calcification, which increases cardiovascular and other causes of mortality [1, 2] , is highly prevalent in dialysis patients. Factors affecting vascular calcification in dialysis patients include advanced age, derangement of calcium-phosphate metabolism [2, 3, 4] , and diabetes [5, 6, 7] . However, specific factors affecting vascular calcification have not been studied using large numbers of diabetic haemodialysis patients. We compared factors affecting peripheral vascular calcification between haemodialysis patients with and without diabetes and found that the strongest predictor for vascular calcification in haemodialysis patients with diabetes is poor glycaemic control.
Subjects and methods
A total of 501 patients with haemodialysis for more than 3 months were in treatment at Shirasagi Hospital Kidney Center in December 1999, including 109 patients with diabetes and 392 patients without diabetes. Of these, 89 patients with diabetes and 332 patients without diabetes gave their informed consent, and their clinical data were obtained. This percentage of diabetics patients (21.1%) is close to the ratio of the entire dialysis population in Japan at the end of 1999 (25.1%, n=185 688). Diabetic patients in our cohort consisted of 53 men and 36 women, and their ages ranged from 37 to 79 years old (62±10; means ± SD). Of 89 patients, 42 were treated with insulin, 22 with oral antidiabetic drugs, and 25 with diet only. Patients without diabetes in our cohort consisted of 192 men and 140 women, and their age ranged from 28 to 87 years old (59±13; means ± SD). There were no significant differences in the male-to-female ratio or age between diabetic and non-diabetic patients. The duration of haemodialysis in diabetic patients was significantly shorter than that of non-diabetic patients (56±39 months vs 102±74 months, respectively, p<0.001).
In December 1999, hand roentgenography was carried out in each patient at a voltage of 45 kV. Vascular calcification of the hand arteries distal to the wrist joints was evaluated by one of the authors who was unaware of other patient data. Blood was taken before dialysis in a non-fasting condition to measure HbA 1C (in diabetic patients only) and serum calcium and phosphate (in all patients). The mean values of three measurements during the 3 months before roentgenography were used for analysis. Serum intact parathyroid hormone (intact PTH) was measured once at the time of roentogenography.
Data were expressed as the means ± SD. A chi-squared test was used to compare the prevalence of vascular calcification of the hand arteries between diabetic and non-diabetic patients. Unpaired Student's t test was used to compare clinical parameters between patients with and without vascular calcification. Multivariate logistic regression analyses were used to explore the combined effect of factors affecting vascular calcification.
Results
Of 332 non-diabetic patients, there were 45 patients (13.6%) with vascular calcification and of 89 diabetic patients, there were 42 patients (47.1%) with vascular calcification. The prevalence of vascular calcification in diabetic patients was higher than in non-diabetic patients (p<0.001).
Between non-diabetic patients with and without vascular calcification, differences were seen in phosphate concentration ( Multivariate logistic regression analyses were done to explore the combined effect of factors affecting vascular calcification. In non-diabetic patients such factors were advanced age, longer duration of haemodialysis, increased phosphate concentrations, male gender, and lower predialysis diastolic pressure (Table 1). In diabetic patients, significant predictors for vascular calcification were higher values of HbA 1C and longer duration of haemodialysis ( Table 2 ). The latter analysis showed that a 1% increase in HbA 1C increased the risk of calcification by 2.1-fold (95% CI higher HbA 1C , while phosphate and calcium were not significant. This study shows that risk factors for vascular calcification differ in diabetic and non-diabetic patients with end-stage renal failure. Although glycaemic control is emphasised in diabetic patients to prevent progression of nephropathy before the need for dialysis [9, 10] , our findings provide new evidence that glycaemic control remains critical in end-stage renal disease. Glycaemic control is therefore important even in diabetic patients with end-stage renal disease.
